Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in doxorubicin-induced apoptosis in rat cardiac myocytes

Oxidative stress is implicated in the pathogenesis of doxorubicin-induced apoptosis in cardiac myocytes. However, the precise mechanism remains uncertain. We identified an apoptosis-inducing humoral factor, in a conditioned medium from cardiac myocytes subjected to hypoxia/reoxygenation, to be 69th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cardiology 2022-02, Vol.348, p.119-124
Hauptverfasser: Yao, Takako, Fujimura, Tsutomu, Murayama, Kimie, Okumura, Ko, Seko, Yoshinori
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124
container_issue
container_start_page 119
container_title International journal of cardiology
container_volume 348
creator Yao, Takako
Fujimura, Tsutomu
Murayama, Kimie
Okumura, Ko
Seko, Yoshinori
description Oxidative stress is implicated in the pathogenesis of doxorubicin-induced apoptosis in cardiac myocytes. However, the precise mechanism remains uncertain. We identified an apoptosis-inducing humoral factor, in a conditioned medium from cardiac myocytes subjected to hypoxia/reoxygenation, to be 69th tyrosine-sulfated eukaryotic translation initiation factor 5A (eIF5A). We named this novel secreted form of eIF5A, Oxidative stress-Responsive Apoptosis Inducing Protein (ORAIP). We confirmed that ischemia/reperfusion, ultraviolet-irradiation, and ionizing radiation significantly increased plasma levels of ORAIP in vivo, supporting that secretion of ORAIP is specific to the oxidative stress. To investigate the role of ORAIP in doxorubicin-induced apoptosis of cardiac myocytes. Methods: We analyzed plasma levels of ORAIP in rats treated with doxorubicin (10 mg/Kg) in vivo, and the effects of neutralizing anti-ORAIP monoclonal antibody (mAb) on doxorubicin-induced apoptosis of cardiac myocytes in vitro. Results: The (mean ± SE) plasma ORAIP levels before doxorubicin administration were (13.7 ± 2.7) ng/mL, they markedly increased with peak levels ([178.6 ± 6.5] ng/mL, p 
doi_str_mv 10.1016/j.ijcard.2021.11.085
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2607303193</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527321019756</els_id><sourcerecordid>2607303193</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-4cee26e94462cf3512e1452ced6555ea665d11c37d0c5fb4ec520c9c10aa903b3</originalsourceid><addsrcrecordid>eNp9kc1qGzEUhUVJady0bxCKlslipvqdn00ghCQNBFxKshby1XWQGY-mkibED9F3rhynhW66kUB85557dAg55azmjDdfN7XfgI2uFkzwmvOadfodWfCuVRVvtToii4K1lRatPCYfU9owxlTfdx_IsVRdo1gnF-TX8sU7m_0z0pQjplSVYwpj2r_YKUw5JJ-oH90MfnyiUwwZ_UjPlj8u776f02mwu0QtheizBzvQGAYsOHXhJcR55YuqelWj-2cejTbT_f7eAt3uAuwypk_k_doOCT-_3Sfk8eb64epbdb-8vbu6vK9AiS5XChBFg71SjYC11FwgV1oUi0ZrjbZptOMcZOsY6PVKIWjBoAfOrO2ZXMkTcnaYW-L8nDFls_UJcBjsiGFORjSslUzyXhZUHVCIIaWIazNFv7VxZzgz-yLMxhyKMPsiDOemFFFkX94c5tUW3V_Rn58vwMUBwJLz2WM0CTyOJYOPCNm44P_v8BuKr56F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2607303193</pqid></control><display><type>article</type><title>Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in doxorubicin-induced apoptosis in rat cardiac myocytes</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Yao, Takako ; Fujimura, Tsutomu ; Murayama, Kimie ; Okumura, Ko ; Seko, Yoshinori</creator><creatorcontrib>Yao, Takako ; Fujimura, Tsutomu ; Murayama, Kimie ; Okumura, Ko ; Seko, Yoshinori</creatorcontrib><description>Oxidative stress is implicated in the pathogenesis of doxorubicin-induced apoptosis in cardiac myocytes. However, the precise mechanism remains uncertain. We identified an apoptosis-inducing humoral factor, in a conditioned medium from cardiac myocytes subjected to hypoxia/reoxygenation, to be 69th tyrosine-sulfated eukaryotic translation initiation factor 5A (eIF5A). We named this novel secreted form of eIF5A, Oxidative stress-Responsive Apoptosis Inducing Protein (ORAIP). We confirmed that ischemia/reperfusion, ultraviolet-irradiation, and ionizing radiation significantly increased plasma levels of ORAIP in vivo, supporting that secretion of ORAIP is specific to the oxidative stress. To investigate the role of ORAIP in doxorubicin-induced apoptosis of cardiac myocytes. Methods: We analyzed plasma levels of ORAIP in rats treated with doxorubicin (10 mg/Kg) in vivo, and the effects of neutralizing anti-ORAIP monoclonal antibody (mAb) on doxorubicin-induced apoptosis of cardiac myocytes in vitro. Results: The (mean ± SE) plasma ORAIP levels before doxorubicin administration were (13.7 ± 2.7) ng/mL, they markedly increased with peak levels ([178.6 ± 6.5] ng/mL, p &lt; 0.00001, vs. before administration) at 20 to 60 min after doxorubicin administration, then gradually decreased to (118.0 ± 4.8) ng/mL at 120 min. Treatment with a neutralizing anti-ORAIP mAb significantly (nearly 50%) suppressed doxorubicin-induced apoptosis of cardiac myocytes. Conclusions: These data indicate that doxorubicin induces oxidative stress resulting in the strong expression of ORAIP in cardiac myocytes and marked secretion of ORAIP into peripheral circulation. This strongly suggests that ORAIP can be a novel sensitive biomarker as well as a possible therapeutic target for doxorubicin-induced cell injury in anti-cancer therapy. •Oxidative stress plays a critical role in doxorubicin-induced apoptosis of cells.•EIF5A is secreted from cells in response to oxidative stress and induces apoptosis.•Doxorubicin-induced apoptosis of cardiac myocytes is partially mediated by ORAIP.•ORAIP can be a sensitive biomarker for doxorubicin-induced apoptosis.•ORAIP may be a possible therapeutic target for doxorubicin-induced apoptosis.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2021.11.085</identifier><identifier>PMID: 34864083</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Apoptosis ; Apoptosis Regulatory Proteins ; Cardiac myocytes ; Doxorubicin ; Eukaryotic translation initiation factor 5A (eIF5A) ; Myocytes, Cardiac - metabolism ; Oxidative Stress ; Oxidative stress-responsive apoptosis inducing protein (ORAIP) ; Rats</subject><ispartof>International journal of cardiology, 2022-02, Vol.348, p.119-124</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-4cee26e94462cf3512e1452ced6555ea665d11c37d0c5fb4ec520c9c10aa903b3</citedby><cites>FETCH-LOGICAL-c428t-4cee26e94462cf3512e1452ced6555ea665d11c37d0c5fb4ec520c9c10aa903b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijcard.2021.11.085$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34864083$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yao, Takako</creatorcontrib><creatorcontrib>Fujimura, Tsutomu</creatorcontrib><creatorcontrib>Murayama, Kimie</creatorcontrib><creatorcontrib>Okumura, Ko</creatorcontrib><creatorcontrib>Seko, Yoshinori</creatorcontrib><title>Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in doxorubicin-induced apoptosis in rat cardiac myocytes</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>Oxidative stress is implicated in the pathogenesis of doxorubicin-induced apoptosis in cardiac myocytes. However, the precise mechanism remains uncertain. We identified an apoptosis-inducing humoral factor, in a conditioned medium from cardiac myocytes subjected to hypoxia/reoxygenation, to be 69th tyrosine-sulfated eukaryotic translation initiation factor 5A (eIF5A). We named this novel secreted form of eIF5A, Oxidative stress-Responsive Apoptosis Inducing Protein (ORAIP). We confirmed that ischemia/reperfusion, ultraviolet-irradiation, and ionizing radiation significantly increased plasma levels of ORAIP in vivo, supporting that secretion of ORAIP is specific to the oxidative stress. To investigate the role of ORAIP in doxorubicin-induced apoptosis of cardiac myocytes. Methods: We analyzed plasma levels of ORAIP in rats treated with doxorubicin (10 mg/Kg) in vivo, and the effects of neutralizing anti-ORAIP monoclonal antibody (mAb) on doxorubicin-induced apoptosis of cardiac myocytes in vitro. Results: The (mean ± SE) plasma ORAIP levels before doxorubicin administration were (13.7 ± 2.7) ng/mL, they markedly increased with peak levels ([178.6 ± 6.5] ng/mL, p &lt; 0.00001, vs. before administration) at 20 to 60 min after doxorubicin administration, then gradually decreased to (118.0 ± 4.8) ng/mL at 120 min. Treatment with a neutralizing anti-ORAIP mAb significantly (nearly 50%) suppressed doxorubicin-induced apoptosis of cardiac myocytes. Conclusions: These data indicate that doxorubicin induces oxidative stress resulting in the strong expression of ORAIP in cardiac myocytes and marked secretion of ORAIP into peripheral circulation. This strongly suggests that ORAIP can be a novel sensitive biomarker as well as a possible therapeutic target for doxorubicin-induced cell injury in anti-cancer therapy. •Oxidative stress plays a critical role in doxorubicin-induced apoptosis of cells.•EIF5A is secreted from cells in response to oxidative stress and induces apoptosis.•Doxorubicin-induced apoptosis of cardiac myocytes is partially mediated by ORAIP.•ORAIP can be a sensitive biomarker for doxorubicin-induced apoptosis.•ORAIP may be a possible therapeutic target for doxorubicin-induced apoptosis.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis Regulatory Proteins</subject><subject>Cardiac myocytes</subject><subject>Doxorubicin</subject><subject>Eukaryotic translation initiation factor 5A (eIF5A)</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Oxidative Stress</subject><subject>Oxidative stress-responsive apoptosis inducing protein (ORAIP)</subject><subject>Rats</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1qGzEUhUVJady0bxCKlslipvqdn00ghCQNBFxKshby1XWQGY-mkibED9F3rhynhW66kUB85557dAg55azmjDdfN7XfgI2uFkzwmvOadfodWfCuVRVvtToii4K1lRatPCYfU9owxlTfdx_IsVRdo1gnF-TX8sU7m_0z0pQjplSVYwpj2r_YKUw5JJ-oH90MfnyiUwwZ_UjPlj8u776f02mwu0QtheizBzvQGAYsOHXhJcR55YuqelWj-2cejTbT_f7eAt3uAuwypk_k_doOCT-_3Sfk8eb64epbdb-8vbu6vK9AiS5XChBFg71SjYC11FwgV1oUi0ZrjbZptOMcZOsY6PVKIWjBoAfOrO2ZXMkTcnaYW-L8nDFls_UJcBjsiGFORjSslUzyXhZUHVCIIaWIazNFv7VxZzgz-yLMxhyKMPsiDOemFFFkX94c5tUW3V_Rn58vwMUBwJLz2WM0CTyOJYOPCNm44P_v8BuKr56F</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Yao, Takako</creator><creator>Fujimura, Tsutomu</creator><creator>Murayama, Kimie</creator><creator>Okumura, Ko</creator><creator>Seko, Yoshinori</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220201</creationdate><title>Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in doxorubicin-induced apoptosis in rat cardiac myocytes</title><author>Yao, Takako ; Fujimura, Tsutomu ; Murayama, Kimie ; Okumura, Ko ; Seko, Yoshinori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-4cee26e94462cf3512e1452ced6555ea665d11c37d0c5fb4ec520c9c10aa903b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis Regulatory Proteins</topic><topic>Cardiac myocytes</topic><topic>Doxorubicin</topic><topic>Eukaryotic translation initiation factor 5A (eIF5A)</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Oxidative Stress</topic><topic>Oxidative stress-responsive apoptosis inducing protein (ORAIP)</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yao, Takako</creatorcontrib><creatorcontrib>Fujimura, Tsutomu</creatorcontrib><creatorcontrib>Murayama, Kimie</creatorcontrib><creatorcontrib>Okumura, Ko</creatorcontrib><creatorcontrib>Seko, Yoshinori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yao, Takako</au><au>Fujimura, Tsutomu</au><au>Murayama, Kimie</au><au>Okumura, Ko</au><au>Seko, Yoshinori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in doxorubicin-induced apoptosis in rat cardiac myocytes</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>348</volume><spage>119</spage><epage>124</epage><pages>119-124</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><abstract>Oxidative stress is implicated in the pathogenesis of doxorubicin-induced apoptosis in cardiac myocytes. However, the precise mechanism remains uncertain. We identified an apoptosis-inducing humoral factor, in a conditioned medium from cardiac myocytes subjected to hypoxia/reoxygenation, to be 69th tyrosine-sulfated eukaryotic translation initiation factor 5A (eIF5A). We named this novel secreted form of eIF5A, Oxidative stress-Responsive Apoptosis Inducing Protein (ORAIP). We confirmed that ischemia/reperfusion, ultraviolet-irradiation, and ionizing radiation significantly increased plasma levels of ORAIP in vivo, supporting that secretion of ORAIP is specific to the oxidative stress. To investigate the role of ORAIP in doxorubicin-induced apoptosis of cardiac myocytes. Methods: We analyzed plasma levels of ORAIP in rats treated with doxorubicin (10 mg/Kg) in vivo, and the effects of neutralizing anti-ORAIP monoclonal antibody (mAb) on doxorubicin-induced apoptosis of cardiac myocytes in vitro. Results: The (mean ± SE) plasma ORAIP levels before doxorubicin administration were (13.7 ± 2.7) ng/mL, they markedly increased with peak levels ([178.6 ± 6.5] ng/mL, p &lt; 0.00001, vs. before administration) at 20 to 60 min after doxorubicin administration, then gradually decreased to (118.0 ± 4.8) ng/mL at 120 min. Treatment with a neutralizing anti-ORAIP mAb significantly (nearly 50%) suppressed doxorubicin-induced apoptosis of cardiac myocytes. Conclusions: These data indicate that doxorubicin induces oxidative stress resulting in the strong expression of ORAIP in cardiac myocytes and marked secretion of ORAIP into peripheral circulation. This strongly suggests that ORAIP can be a novel sensitive biomarker as well as a possible therapeutic target for doxorubicin-induced cell injury in anti-cancer therapy. •Oxidative stress plays a critical role in doxorubicin-induced apoptosis of cells.•EIF5A is secreted from cells in response to oxidative stress and induces apoptosis.•Doxorubicin-induced apoptosis of cardiac myocytes is partially mediated by ORAIP.•ORAIP can be a sensitive biomarker for doxorubicin-induced apoptosis.•ORAIP may be a possible therapeutic target for doxorubicin-induced apoptosis.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34864083</pmid><doi>10.1016/j.ijcard.2021.11.085</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-5273
ispartof International journal of cardiology, 2022-02, Vol.348, p.119-124
issn 0167-5273
1874-1754
language eng
recordid cdi_proquest_miscellaneous_2607303193
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Apoptosis
Apoptosis Regulatory Proteins
Cardiac myocytes
Doxorubicin
Eukaryotic translation initiation factor 5A (eIF5A)
Myocytes, Cardiac - metabolism
Oxidative Stress
Oxidative stress-responsive apoptosis inducing protein (ORAIP)
Rats
title Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in doxorubicin-induced apoptosis in rat cardiac myocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T12%3A56%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxidative%20stress-responsive%20apoptosis%20inducing%20protein%20(ORAIP)%20plays%20a%20critical%20role%20in%20doxorubicin-induced%20apoptosis%20in%20rat%20cardiac%20myocytes&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Yao,%20Takako&rft.date=2022-02-01&rft.volume=348&rft.spage=119&rft.epage=124&rft.pages=119-124&rft.issn=0167-5273&rft.eissn=1874-1754&rft_id=info:doi/10.1016/j.ijcard.2021.11.085&rft_dat=%3Cproquest_cross%3E2607303193%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2607303193&rft_id=info:pmid/34864083&rft_els_id=S0167527321019756&rfr_iscdi=true